Gijung Kwak

Gijung Kwak is a Postdoctoral Research Fellow at the University of Maryland School of Medicine (since 2023) and previously at the Center for Nanomedicine, Wilmer Eye Institute, Johns Hopkins University School of Medicine (2020-2023). He specializes in advanced drug delivery systems, focusing on non-viral gene delivery, polymeric nanoparticles, and extracellular vesicles for targeting brain, lung, and ocular tissues.

• B.S., INHA University (2015)
• Ph.D., Korea University (2020)
• Visiting Researcher, UC Berkeley (2018-2019)

His research spans critical areas in translational nanomedicine, including RNAi-based cancer therapies, bioreducible gene delivery platforms, and sustained release formulations for wound healing. Recent work explores synergistic tumor suppression, ocular gene delivery, and dual-arm strategies for brain tumor targeting.

Publication trends reveal expertise in pDNA/mRNA/RNAi delivery, polymer nanotechnology, and macrophage modulation. Collaborations include leading researchers like Prof. Jung Soo Suk and Phillip B. Messersmith.